| Literature DB >> 30169512 |
Ana L Ramírez1,2, Sonja Hall-Mendelin3, Stephen L Doggett4, Glen R Hewitson3, Jamie L McMahon3, Scott A Ritchie1,2, Andrew F van den Hurk3.
Abstract
BACKGROUND: Emerging and re-emerging arthropod-borne viruses (arboviruses) cause human and animal disease globally. Field and laboratory investigation of mosquito-borne arboviruses requires analysis of mosquito samples, either individually, in pools, or a body component, or secretion such as saliva. We assessed the applicability of mosquito excreta as a sample type that could be utilized during studies of Ross River and West Nile viruses, which could be applied to the study of other arboviruses. METHODOLOGY/PRINCIPALEntities:
Mesh:
Year: 2018 PMID: 30169512 PMCID: PMC6136815 DOI: 10.1371/journal.pntd.0006771
Source DB: PubMed Journal: PLoS Negl Trop Dis ISSN: 1935-2727
Infection, dissemination and transmission rates in Ae. vigilax exposed to 108.1±0.1TCID50/mL of RRV tested at different days post exposure (PE).
| Day PE | Infection | Dissemination | Dissemination/ Infection | Transmission | Transmission/ Dissemination | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| n | % | 95%CI | n | % | 95%CI | n | % | 95%CI | n | % | 95%CI | n | % | 95%CI | |
| 8 | 19 | 79 | 56–92 | 19 | 79 | 56–92 | 15 | 100 | 76–100 | 19 | 47 | 27–68 | 15 | 60 | 36–80 |
| 11 | 19 | 89 | 67–98 | 19 | 89 | 67–98 | 17 | 100 | 78–100 | 19 | 32 | 15–54 | 17 | 35 | 17–59 |
| 15 | 17 | 76 | 52–91 | 17 | 76 | 52–91 | 13 | 100 | 73–100 | 17 | 29 | 13–53 | 13 | 38 | 18–65 |
| Total | 55 | 82 | 69–90 | 55 | 82 | 69–90 | 45 | 100 | 91–100 | 55 | 36 | 25–50 | 45 | 44 | 31–59 |
aNumber of mosquitoes tested, percentage of mosquitoes containing virus in their bodies, 95% confidence intervals
bNumber of mosquitoes tested, percentage of mosquitoes containing virus in their legs+wing, 95% confidence intervals
cNumber of infected mosquitoes, percentage of infected mosquitoes containing virus in their legs+wings, 95%CI, percentage, 95% confidence intervals
dNumber of mosquitoes tested, percentage of mosquitoes containing virus in their expectorate collected in capillary tubes, 95% confidence intervals
eNumber of mosquitoes with disseminated infection, percentage of mosquitoes with disseminated infection containing virus in their expectorate collected in capillary tubes, 95% confidence intervals
Infection, dissemination and transmission rates in Cx. annulirostris exposed to 107.3 ±0.3TCID50/mL of WNVKUN tested at different days post exposure (PE).
| Day PE | Infection | Dissemination | Dissemination/ Infection | Transmission | Transmission/ Dissemination | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| n | % | 95%CI | n | % | 95%CI | n | % | 95%CI | n | % | 95%CI | n | % | 95%CI | |
| 7 | 20 | 40 | 22–61 | 20 | 15 | 4–37 | 8 | 38 | 13–70 | 20 | 0 | 0–19 | 3 | 0 | 0–62 |
| 12 | 20 | 45 | 26–66 | 20 | 40 | 22–61 | 9 | 89 | 54–100 | 20 | 15 | 4–37 | 8 | 38 | 13–70 |
| 15 | 19 | 42 | 23–64 | 19 | 42 | 23–64 | 8 | 100 | 63–100 | 19 | 26 | 11–49 | 8 | 63 | 30–87 |
| Total | 59 | 42 | 31–55 | 59 | 32 | 22–45 | 25 | 76 | 56–89 | 59 | 14 | 7–25 | 19 | 42 | 23–64 |
aNumber of mosquitoes tested, percentage of mosquitoes containing virus in their bodies, 95% confidence intervals
bNumber of mosquitoes tested, percentage of mosquitoes containing virus in their legs+wing, 95% confidence intervals
cNumber of infected mosquitoes, percentage of infected mosquitoes containing virus in their legs+wings, 95%CI, percentage, 95% confidence intervals
dNumber of mosquitoes tested, percentage of mosquitoes containing virus in their expectorate collected in capillary tubes, 95% confidence intervals
eNumber of mosquitoes with disseminated infection, percentage of mosquitoes with disseminated infection containing virus in their expectorate collected in capillary tubes, 95% confidence intervals
Fig 1Real-time RT-PCR detection of arboviruses in excreta from 20 batches of 5 mosquitoes.
(A) Detection of RRV RNA from Ae. vigilax excreta collected daily from day 2 to day 15 post exposure (PE) (B) Detection of WNVKUN RNA from Cx. annulirostris excreta collected daily from day 2 to day 15 post exposure (PE). Lower Ct values correspond to a greater amount of viral template; a blank square indicates that viral RNA was not detected. A skull indicates that the container was removed from the experiment due to mortality of all 5 mosquitoes. X = not tested.
Fig 2Detection of RRV RNA by real time RT-PCR in excreta swabs and saliva expectorates (filter paper cards).
Samples collected over 18–24 h from individual Ae. vigilax sampled at different timepoints post exposure (PE). Bars denote medians. P<0.05 (*), P<0.001 (**), P<0.0001(***). Each point represents an individual mosquito.
Fig 3Detection of WNVKUN RNA by real time RT-PCR in excreta swabs and saliva expectorates (filter paper cards).
Samples collected over 18–24 h from individual Cx. annulirostris sampled at different timepoints post exposure. Bars denote medians. P<0.05 (*), P<0.001 (**), P<0.0001(***). Each point represents an individual mosquito. No mosquitoes expectorated virus onto filter paper cards on days 7 and 12 PE.
Fig 4Detection of viral RNA in excreta and saliva expectorates (filter paper cards) from mosquito batches on day 15 post-exposure.
(A) Detection of RRV RNA by real time RT-PCR in excreta and filter paper cards collected over 18–24 h from batches of 5 Ae. vigilax. (B) Detection of WNVKUN RNA by RT-PCR in excreta and filter paper cards collected over 18–24 h from batches of 5 Cx. annulirostris.
Proportion of excreta and saliva (filter paper cards) from individual mosquitoes positive for viral RNA by real-time RT-PCR tested at different days post exposure (PE).
| Mosquito | Virus | Day PE | n | Excreta | Saliva | ||
|---|---|---|---|---|---|---|---|
| % | 95%CI | % | 95%CI | ||||
| RRV | 8 | 19 | 68 | 46–85 | 16 | 5–38 | |
| 11 | 19 | 53 | 32–73 | 5 | 0–26 | ||
| 15 | 17 | 71 | 47–87 | 24 | 9–48 | ||
| Total | 55 | 64 | 50–75 | 14 | 7–26 | ||
| WNVKUN | 7 | 20 | 25 | 11–47 | 0 | 0–19 | |
| 12 | 20 | 30 | 14–52 | 0 | 0–19 | ||
| 15 | 19 | 26 | 11–49 | 11 | 2–33 | ||
| Total | 59 | 27 | 17–40 | 3 | 3–12 | ||
aPercentage of positive excreta samples, 95% confidence intervals
bPercentage of positive saliva samples (filter paper cards), 95% confidence intervals
*Fisher’s exact test two-tailed P-value <0.05 for comparison with excreta